Basics Nautilus Biotechnology, Inc. IPO Date: August 7, 2020 Sector: Healthcare Industry: Biotech Market Cap: $97.51M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 3.24% Avg Daily Range (30 D): $0.03 | 4.26% Avg Daily Range (90 D): $0.04 | 4.06% Institutional Daily Volume Avg Daily Volume: .17M Avg Daily Volume (30 D): .14M Avg Daily Volume (90 D): .11M Trade Size Avg Trade Size (Sh.): 129 Avg Trade Size (Sh.) (30 D): 197 Avg Trade Size (Sh.) (90 D): 190 Institutional Trades Total Inst.Trades: 34 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $.8M Avg Inst. Trade (90 D): $.8M Avg Inst. Trade Volume: .34M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.96M Avg Closing Trade (30 D): $.83M Avg Closing Trade (90 D): $.83M Avg Closing Volume: 485.16K         News May 3, 2024 @ 4:00 PM Nautilus Biotechnology (NAUT) Upgraded to Buy: Her... Source: Zacks Equity Research Apr 30, 2024 @ 12:00 PM Nautilus Biotechnology Reports First Quarter 2024 ... Source: Nautilus Biotechnology Inc. Feb 22, 2024 @ 1:00 PM Nautilus Biotechnology to Participate in the TD Co... Source: Nautilus Biotechnology Inc. Nov 1, 2023 @ 12:05 PM Nautilus Biotechnology Appoints Martin Huber, Ph.D... Source: Nautilus Biotechnology Inc. Oct 31, 2023 @ 12:05 PM Nautilus Biotechnology Reports Third Quarter 2023 ... Source: Nautilus Biotechnology Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.13 $-.13 $-.14 Diluted EPS $-.13 $-.13 $-.14 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -16.61M $ -16.45M $ -18.01M Operating Income / Loss $ $ $ Cost of Revenue $ $ $ Net Cash Flow $ 5.59M $ -20.48M $ -.84M PE Ratio